Insider · CIK 0001237253

Bisaro Paul

Reports to the SEC for 10 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001237253

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+4,406 sh	—	—	46,749
2026-06-04	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+59.7K sh	—	—	157,142
2026-06-02	Keenova Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+2,685 sh	—	—	6,863
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,685 sh	—	—	42,343
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,197 sh	—	—	45,028
2026-06-02	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−619 sh	—	—	6,244
2026-05-14	MYGNMYRIAD GENETICS INCP Purchase	Director	PPurchase	+7,500 sh	$3.69	+$27.6K	97,441
2026-05-13	ZTSZoetis Inc.P Purchase	Director	PPurchase	+2,000 sh	$75.88	+$152K	27,862
2026-02-23	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+3,984 sh	—	—	47,225
2026-02-19	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,619.333 sh	—	—	0
2026-02-19	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,619 sh	—	—	25,862
2026-02-18	ZTSZoetis Inc. · Restricted Stock UnitA Award	Director	AAward	+1,936 sh	—	—	1,936
2026-01-01	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,466 sh	—	—	46,255
2026-01-01	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,014 sh	—	—	43,241
2026-01-01	Keenova Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+3,014 sh	—	—	5,032
2026-01-01	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−854 sh	—	—	4,178
2025-08-14	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+4,062 sh	—	—	40,538
2025-07-31	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+27.4K sh	—	—	36,476
2025-06-05	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+49.8K sh	—	—	89,941
2025-02-19	ZTSZoetis Inc. · Restricted Stock UnitA Award	Director	AAward	+1,596 sh	—	—	1,596
2025-02-08	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,225.402 sh	—	—	0
2025-02-08	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,225 sh	—	—	24,243
2025-02-06	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,236 sh	—	—	23,018
2025-02-06	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,236.213 sh	—	—	0
2025-01-01	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,507 sh	—	—	9,119
2025-01-01	Keenova Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+2,507 sh	—	—	2,507
2025-01-01	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,052 sh	—	—	11,626
2025-01-01	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−489 sh	—	—	2,018
2024-06-06	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+15.7K sh	—	—	40,145
2024-02-19	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	−13.7K sh	—	—	13,678
2024-02-10	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,463.394 sh	—	—	1,212.305
2024-02-10	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,463 sh	—	—	21,782
2024-02-08	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,493 sh	—	—	20,319
2024-02-08	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,493.265 sh	—	—	0
2024-02-06	ZTSZoetis Inc. · Restricted Stock UnitA Award	Director	AAward	+1,223 sh	—	—	1,223
2023-11-14	Keenova Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2023-06-16	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−3,689 sh	$1.28	−$4,721.92	71,131
2023-06-16	Keenova Therapeutics plcD Disposition to Issuer	Director	DDisposition to Issuer	−39.1K sh	—	—	32,048
2023-06-01	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+7,575 sh	—	—	24,450
2023-03-14	Keenova Therapeutics plcP Purchase	Director	PPurchase	+5,000 sh	$8.47	+$42.3K	74,820
2023-02-11	ZTSZoetis Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1,626.844 sh	—	—	2,651.93
2023-02-11	ZTSZoetis Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,626 sh	—	—	18,826
2023-02-08	ZTSZoetis Inc. · Restricted Stock UnitA Award	Director	AAward	+1,480 sh	—	—	1,480
2023-01-03	Keenova Therapeutics plcA Award	Director	AAward	+39.1K sh	—	—	69,820
2022-10-31	MYGNMYRIAD GENETICS INCA Award	Director	AAward	+16.9K sh	—	—	16,875
2022-09-29	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2022-08-18	TXMDTherapeuticsMD, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,984 sh	—	—	5,922
2022-08-18	TXMDTherapeuticsMD, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,984 sh	—	—	0
2022-08-16	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−44.4K sh	—	—	30,737
2022-07-01	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+75.1K sh	—	—	75,091

Recent filings

Accepted (ET)
Jul 174
Bisaro Paul0001104659-26-084774
SEC(opens sec.gov)
Jun 54
Bisaro Paul0001237253-26-000004
SEC(opens sec.gov)
Jun 44
Bisaro Paul0001104659-26-070520
SEC(opens sec.gov)
May 144
Bisaro Paul0001237253-26-000002
SEC(opens sec.gov)
May 134
Bisaro Paul0001628280-26-034642
SEC(opens sec.gov)
Feb 254
Bisaro Paul0001104659-26-019921
SEC(opens sec.gov)
Feb 234
Bisaro Paul0001628280-26-010671
SEC(opens sec.gov)
Feb 194
Bisaro Paul0001628280-26-009978
SEC(opens sec.gov)
Jan 54
Bisaro Paul0001104659-26-000777
SEC(opens sec.gov)
Aug 184
Bisaro Paul0001104659-25-079941
SEC(opens sec.gov)
Aug 44
Bisaro Paul0001104659-25-073785
SEC(opens sec.gov)
Jun 64
Bisaro Paul0001628280-25-029979
SEC(opens sec.gov)
Feb 204
BISARO PAUL0001555280-25-000123
SEC(opens sec.gov)

Companies

Address

440 ROUTE 22 EAST, SUITE 302

BRIDGEWATER, NJ, 08807